PIAS3, SOCS3, SHP1, and SHP2 are known negative regulators of STAT3 signaling [12,13,14,15], and were examined to explore the molecular mechanism for inhibited STAT3 signaling in GBM cells treated with Res and TMZ. Here, STAT3 is linked to glioblastoma.